Industry / Egypt
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Government Allows Limited Drug Price Rises
January 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Egypt's Ministry of Health and Population has bowed to pressure from manufacturers worried by rising raw material costs and agreed an 8% increase in the price of 265 drugs, representing 3.4% of the pharmaceuticals registered in Egypt. BMI considers the increase to be long overdue - some of the drugs on the list have remained at the same price for more than 10 years despite significant rises in costs of production over the